Trial
NCT03143543
Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder
Phase ITERMINATEDREGULATORYConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Cocaine-Related Disorders
Intervention
Group A Lorcaserin (10mg)
Why stopped
FDA removal of drug from the market due to cancer risks
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-27